Novel Insights on SGLT-2 Inhibitors 1st/2020

Key Features :

• This book provides detailed information on the novel drug class SGLT-2 inhibitors for the treatment of diabetes.
• All current evidences, studies and available data have been incorporated in the writing of this book to bring to the readers an updated overview of this novel drug class.
• An in depth search of literature on all topics traces how the SGLT-2 inhibitors have evolved and are now a preferred option in management of type 2 diabetes, with promising data emerging on their use in type 1 diabetes as well.
• The book has been written in simple language and a standard pattern with a crisp introduction of the topic to brief the reader on what to expect in the text, followed at the end by a short conclusion that sums up the text for quick reference of its readers
• The book is aimed at all health care practitioners, physicians and medical students/postgraduates with an avid interest in the latest advances in the evolution of this drug class for diabetes management
• Written by experts in the field of diabetes with a vast clinical experience with these agents.